Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc S Raab

Showing results (91-100 of 178) with videos related to

Pageof 18
Sort By:
Blood|February 8, 2007
Protein kinase C inhibitor enzastaurin induces in vitro and in vivo antitumor activity in Waldenstrom macroglobulinemiaAnne-Sophie Moreau, Xiaoying Jia, Hai T Ngo, et al.
Leukemia|October 11, 2023
High-throughput electron tomography identifies centriole over-elongation as an early event in plasma cell disordersSebastian Köhrer, Tobias Dittrich, Martin Schorb, et al.
Haematologica|June 29, 2023
Clonal hematopoiesis with <i>DNMT3A</i> and <i>PPM1D</i> mutations impairs regeneration in autologous stem cell transplant recipientsPatrick Stelmach, Sarah Richter, Sandra Sauer, et al.
Haematologica|January 20, 2022
Comprehensive genomic analysis of refractory multiple myeloma reveals a complex mutational landscape associated with drug resistance and novel therapeutic vulnerabilitiesNicola Giesen, Nagarajan Paramasivam, Umut H Toprak, et al.
Haematologica|June 7, 2021
Chromosome 1q21 abnormalities refine outcome prediction in patients with multiple myeloma - a meta-analysis of 2,596 trial patientsNiels Weinhold, Hans J Salwender, David A Cairns, et al.
Frontiers in Immunology|November 30, 2023
RNA-sequencing based first choice of treatment and determination of risk in multiple myelomaMartina Emde-Rajaratnam, Susanne Beck, Vladimir Benes, et al.
Blood Cancer Journal|January 4, 2023
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myelomaElias K Mai, Stefanie Huhn, Kaya Miah, et al.
Cell Death & Disease|November 18, 2022
An mTORC1 to HRI signaling axis promotes cytotoxicity of proteasome inhibitors in multiple myelomaOdai Darawshi, Barbara Muz, Shiri Gershon Naamat, et al.
Cancer Research|September 4, 2012
GF-15, a novel inhibitor of centrosomal clustering, suppresses tumor cell growth in vitro and in vivoMarc S Raab, Iris Breitkreutz, Simon Anderhub, et al.
Blood|July 27, 2016
Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genesK Martin Kortüm, Elias K Mai, Nur H Hanafiah, et al.
Pageof 18

Showing results (91-100 of 178) with videos related to

Sort By:
Pageof 18
Blood|February 8, 2007
Protein kinase C inhibitor enzastaurin induces in vitro and in vivo antitumor activity in Waldenstrom macroglobulinemiaAnne-Sophie Moreau, Xiaoying Jia, Hai T Ngo, et al.
Leukemia|October 11, 2023
High-throughput electron tomography identifies centriole over-elongation as an early event in plasma cell disordersSebastian Köhrer, Tobias Dittrich, Martin Schorb, et al.
Haematologica|June 29, 2023
Clonal hematopoiesis with <i>DNMT3A</i> and <i>PPM1D</i> mutations impairs regeneration in autologous stem cell transplant recipientsPatrick Stelmach, Sarah Richter, Sandra Sauer, et al.
Haematologica|January 20, 2022
Comprehensive genomic analysis of refractory multiple myeloma reveals a complex mutational landscape associated with drug resistance and novel therapeutic vulnerabilitiesNicola Giesen, Nagarajan Paramasivam, Umut H Toprak, et al.
Haematologica|June 7, 2021
Chromosome 1q21 abnormalities refine outcome prediction in patients with multiple myeloma - a meta-analysis of 2,596 trial patientsNiels Weinhold, Hans J Salwender, David A Cairns, et al.
Frontiers in Immunology|November 30, 2023
RNA-sequencing based first choice of treatment and determination of risk in multiple myelomaMartina Emde-Rajaratnam, Susanne Beck, Vladimir Benes, et al.
Blood Cancer Journal|January 4, 2023
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myelomaElias K Mai, Stefanie Huhn, Kaya Miah, et al.
Cell Death & Disease|November 18, 2022
An mTORC1 to HRI signaling axis promotes cytotoxicity of proteasome inhibitors in multiple myelomaOdai Darawshi, Barbara Muz, Shiri Gershon Naamat, et al.
Cancer Research|September 4, 2012
GF-15, a novel inhibitor of centrosomal clustering, suppresses tumor cell growth in vitro and in vivoMarc S Raab, Iris Breitkreutz, Simon Anderhub, et al.
Blood|July 27, 2016
Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genesK Martin Kortüm, Elias K Mai, Nur H Hanafiah, et al.
Pageof 18